Skorpios Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$169K Hold
1,686
0.32% 2
2025
Q2
$140K Hold
1,686
0.38% 2
2025
Q1
$137K Hold
1,686
0.3% 2
2024
Q4
$152K Hold
1,686
0.2% 2
2024
Q3
$167K Hold
1,686
0.15% 2
2024
Q2
$156K Hold
1,686
0.11% 2
2024
Q1
$160K Hold
1,686
0.08% 2
2023
Q4
$151K Hold
1,686
0.2% 2
2023
Q3
$123K Hold
1,686
0.22% 2
2023
Q2
$140K Hold
1,686
0.06% 4
2023
Q1
$128K Hold
1,686
0.05% 4
2022
Q4
$140K Hold
1,686
0.04% 4
2022
Q3
$134K Hold
1,686
0.04% 4
2022
Q2
$125K Hold
1,686
0.05% 4
2022
Q1
$152K Hold
1,686
0.04% 4
2021
Q4
$189K Buy
+1,686
New +$203K 0.04% 4

Other funds holding XBI

Skorpios Trust's XBI Position: Q3 2025 in Review

Skorpios Trust held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2025 at 1,686 shares worth $169K. The position accounts for 0.32% of the portfolio, ranked #2.

Skorpios Trust first reported a position in XBI in Q4 2021 and has held it in 16 quarters since. The position peaked at $189K in Q4 2021. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

  • Skorpios Trust held 1,686 shares of State Street SPDR S&P Biotech ETF worth $169K as of Q3 2025.
  • Skorpios Trust left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2025.
  • State Street SPDR S&P Biotech ETF made up 0.32% of Skorpios Trust's portfolio in Q3 2025, its #2 holding.
  • Skorpios Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 16 quarters since.
  • Skorpios Trust's State Street SPDR S&P Biotech ETF position peaked at $189K in Q4 2021.
  • 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Skorpios Trust's 13F filing for Q3 2025, filed 29 Oct 2025.